Posts Tagged: follow on biologics


The Myth of ‘Trivial’ Drug Patents

Critics of drug patents often claim that when initial drug patents expire, drug companies stuff their patent portfolios with “trivial” patents that unjustifiably extend their patent monopoly …
By David Forman
2 years ago 6

SCOTUS says OK to give notice of commercial marketing before FDA license under Biologics Price Competition and Innovation Act

42 U.S.C. § 262(l) of the Biologics Price Competition and Innovation Act of 2009 (BPCIA) regulates “biosimilars,” biological products that are highly similar to FDA-approved biological products. Section 262(…

Industry Reaction to SCOTUS decision in Sandoz v. Amgen

The Court’s Sandoz v. Amgen decision gutted a statute that had been carefully crafted to facilitate timely resolution of patent disputes and avoid delaying market entry …
By Gene Quinn
3 years ago 2

Exclusive Interview: Jim Greenwood, President & CEO of BIO

On Wednesday, April 21, 2010, I had the pleasure of conducting an exclusive, on the record interview with Jim Greenwood, former Congressman and current President & CEO of BIO. It …
By Gene Quinn
11 years ago 0

Health Care Bill Good for BIO According to Greenwood

Notwithstanding the above, I am conflicted in my feelings. It seems that one of the deals included in the Health Care Bill, provisions aimed at biotechnology, are …
By Gene Quinn
11 years ago 0

BIO Gearing Up for Big Spring 2010, Headlined by Kappos

The Biotechnology Industry Organization (BIO) has just announced that David Kappos, Director of the U.S. Patent and Trademark Office and Under Secretary of Commerce for Intellectual …
By Gene Quinn
11 years ago 0

Fact vs. Fiction: The Truth on Biologics and Biosimilars

For many months we have been hearing about the government attempts to “reform” health care in the United States, and this weekend the United States Senate is …
By Gene Quinn
11 years ago 6

Anti-Innovation Chorus Continues Over Biologics

A press release issued earlier today by the Pharmaceutical Care Management Association (PCMA) explained that a new article published in the New England Journal of Medicine (NEJM) …
By Gene Quinn
11 years ago 7

Why a Global Patent System is a Bad Idea

A little over a week ago, in a blog post written by Microsoft’s Deputy General Counsel Horacio Gutierrez started what will certainly become one of the …
By Gene Quinn
11 years ago 30

Dishonest Roll Call Editorial on Follow on Biologics

Earlier today James Love and James Glassman published what can only be described as an intellectually dishonest op-ed piece on RollCall.com.  The two James either simply …
By Gene Quinn
11 years ago 5

Fixing America’s Health Care System

On Thursday morning, August 13, 2009, CNBC aired a segment titled Fixing America’s Health Care System on Squawk Box, which is CNBC’s longest running program.  Appearing on …
By Gene Quinn
11 years ago 26

Howard Dean Supports Strong Protection for Biologics

Last week, on July 8, 2009, former Presidential Candidate, former Vermont Governor and former Chair of the Democratic National Committee, Howard Dean stepped into the health reform debate, discussing …
By Gene Quinn
11 years ago 5